Germany – Pharmaceutical products – Abschluss von nicht nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Ar
AOK Baden-Württemberg Hauptverwaltung awarded €221K to Fresenius Kabi Deutschland GmbH for Healthcare & Medical in February 2024 — one of 299 awards this buyer has made, in line with its typical award size.
Buying agency
AOK Baden-Württemberg HauptverwaltungWinning supplier
Fresenius Kabi Deutschland GmbHContract description
Germany – Pharmaceutical products – Abschluss von nicht nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren)
Related awards · AOK Baden-Württemberg Hauptverwaltung
299 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-761135-2024enercity AG€1.8M12 Dec 2024 Energy
- ocds-ted-223384-2025Blocher GmbH / blocher partners€1.5M07 Apr 2025 Professional Services
- ocds-ted-220707-2025IBK Ingenieurbüro Kaya GmbH€744K07 Apr 2025 Professional Services
Other wins · Fresenius Kabi Deutschland GmbH
141 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for AOK Baden-Württemberg Hauptverwaltung and Fresenius Kabi Deutschland GmbH — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back